Of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), 85–90% have ANCA, namely anti-myeloperoxidase (MPO) or PR3 antibodies [7, 8]. This evidence concerns the gene MPO and microscopic polyangiitis.